DUBLIN, Ohio — Cardinal Health has appointed to its board a former Schering-Plough executive with 30 years of experience in the pharmaceutical industry.
The appointment of Carrie Cox, 52, is effective immediately. She most recently was an executive vice president with Schering-Plough Corp. and left the company last month after it was acquired by Merck & Co., according to a statement from Cardinal.
Fortune Magazine named Cox to its list of the “50 Most Powerful Women in Business” six times, according to Cardinal.
Cardinal is filling board seats vacated as a result of its spin-off of device company CareFusion. The spin-off cut into Cardinal’s first-quarter earnings and contributed to its $38 million loss for the quarter.
Can regenerative medicine firm TNGN conjure a Medtronic partnership?
Urinary incontinence treatment firm testing device for fecal incontinence
Pain-relief neurostimulation company SPR gets $900K Ohio loan
Nashville medical mart adds biggest tenant yet, a multi-vendor RFID technology showroom
Sign up for MedCity News' e-newsletter, providing medical industry news from across the country.
Sign up
Anyone can blog on MedCity News when they become a "MedCitizen." MedCitizens publish their own thoughts about current medical news and the latest issues in healthcare to the entire MedCity News audience.
Merrill GooznerPharma, device firms kill conflict of interest rule, win accelerated approval
Dr. John D. HalamkaBYOD makes mobile security more complicated
Steven M. Auvil (Sponsored)5 things med tech companies need to know about the Leahy-Smith America Invents Act
Amy SiegelTop 5 anxiety-provoking medtech acronyms
Stephen Schimpff MDIntegrative Medicine Part II — Health Care of the Future
John Mandrola, MDWeighing the risks of Pradaxa vs. the risk of stroke
Comments
Post a comment
No comments yet.
Post a Comment